BioSpace News Archive

Intrexon Corporation and Precigen, Inc. announced their presentation at the JMP Securities Life Sciences Conference in New York.

Rigel Pharmaceuticals, Inc. announced that it will present data on fostamatinib disodium hexahydrate in two posters at the 24th Congress of the European Hematology Association in Amsterdam, The Netherlands, on June 13-16, 2019.

Medicenna Therapeutics Corp. announced that it will host a Key Opinion Leader call and webcast for the investment community on Tuesday, June 18, 2019 at 1 PM, EDT.

State of the art e-commerce platform to offer exclusive products for the pet market

Columbia Care Inc. announced that it is launching its Columbia National Credit program (the “CNC Card”) across the United States, following a successful pilot program in New York.

Mascots from Las Vegas sports teams including the Golden Knights, Aviators, Lights FC, Aces and UNLV teamed up yesterday to welcome the nation’s newest mascot: Miles the Miracle Flights Bear.

Integrated workflow optimization solution improves staff communication and coordination - reducing costs and improving patient satisfaction

Intermittent fasting app reaches milestone number of users looking to track habits and improve metabolic health

First-of-its-kind resource decodes the tax-advantaged tool about to stir up group insurance market

Lumosa Therapeutics announced that the company is ready to commence the Phase 2 proof of concept study for its LT3001, a novel drug for the treatment of acute ischemic stroke that showed good safety, tolerability and pharmacokinetic profiles in its Phase 1 study, as the US FDA has no objections during the 30-day reviewing period on the company’s Investigational New Drug application.